Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 78 entries
Sorted by: Best Match Show Resources per page
Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?.

Therapeutic advances in medical oncology

Bouchart C, Navez J, Closset J, Hendlisz A, Van Gestel D, Moretti L, Van Laethem JL.
PMID: 32684987
Ther Adv Med Oncol. 2020 Jul 07;12:1758835920936093. doi: 10.1177/1758835920936093. eCollection 2020.

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive solid tumours with an estimated 5-year overall survival rate of 7% for all stages combined. In this highly resistant disease that is located in the vicinity of many radiosensitive...

Cite
Bouchart C, Navez J, Closset J, et al. Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?. Ther Adv Med Oncol. 2020;12:1758835920936093doi: 10.1177/1758835920936093.
Bouchart, C., Navez, J., Closset, J., Hendlisz, A., Van Gestel, D., Moretti, L., & Van Laethem, J. L. (2020). Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?. Therapeutic advances in medical oncology, 121758835920936093. https://doi.org/10.1177/1758835920936093
Bouchart, Christelle, et al. "Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?." Therapeutic advances in medical oncology vol. 12 (2020): 1758835920936093. doi: https://doi.org/10.1177/1758835920936093
Bouchart C, Navez J, Closset J, Hendlisz A, Van Gestel D, Moretti L, Van Laethem JL. Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?. Ther Adv Med Oncol. 2020 Jul 07;12:1758835920936093. doi: 10.1177/1758835920936093. eCollection 2020. PMID: 32684987; PMCID: PMC7343368.
Copy Download .nbib Format: NLM
A prospective study on the prevalence and risk factors of poststroke depression.

Cerebrovascular diseases extra

De Ryck A, Brouns R, Fransen E, Geurden M, Van Gestel G, Wilssens I, De Ceulaer L, Mariën P, De Deyn PP, Engelborghs S.
PMID: 23626594
Cerebrovasc Dis Extra. 2013 Jan 26;3(1):1-13. doi: 10.1159/000345557. Print 2013 Jan.

BACKGROUND AND PURPOSE: Poststroke depression (PSD) is common. Early detection of depressive symptoms and identification of patients at risk for PSD are important as PSD negatively affects stroke outcome and costs of medical care. Therefore, the aim of this...

Cite
De Ryck A, Brouns R, Fransen E, et al. A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra. 2013;3(1):1-13doi: 10.1159/000345557.
De Ryck, A., Brouns, R., Fransen, E., Geurden, M., Van Gestel, G., Wilssens, I., De Ceulaer, L., Mariën, P., De Deyn, P. P., & Engelborghs, S. (2013). A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovascular diseases extra, 3(1), 1-13. https://doi.org/10.1159/000345557
De Ryck, A, et al. "A prospective study on the prevalence and risk factors of poststroke depression." Cerebrovascular diseases extra vol. 3,1 (2013): 1-13. doi: https://doi.org/10.1159/000345557
De Ryck A, Brouns R, Fransen E, Geurden M, Van Gestel G, Wilssens I, De Ceulaer L, Mariën P, De Deyn PP, Engelborghs S. A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra. 2013 Jan 26;3(1):1-13. doi: 10.1159/000345557. Print 2013 Jan. PMID: 23626594; PMCID: PMC3567876.
Copy Download .nbib Format: NLM
Amplification of chirality in benzene tricarboxamide helical supramolecular polymers.

Chemical communications (Cambridge, England)

Wilson AJ, van Gestel J, Sijbesma RP, Meijer EW.
PMID: 17057858
Chem Commun (Camb). 2006 Nov 13;(42):4404-6. doi: 10.1039/b610051a. Epub 2006 Sep 13.

The chirality of benzene tricarboxamides is expressed and amplified into the helicity of self-assembled columnar aggregates according to 'sergeants and soldiers' and 'majority rules' principles; the strength of the amplification is analysed quantitatively and the effect of the number...

Cite
Wilson AJ, van Gestel J, Sijbesma RP, et al. Amplification of chirality in benzene tricarboxamide helical supramolecular polymers. Chem Commun (Camb). 2006;(42):4404-6doi: 10.1039/b610051a.
Wilson, A. J., van Gestel, J., Sijbesma, R. P., & Meijer, E. W. (2006). Amplification of chirality in benzene tricarboxamide helical supramolecular polymers. Chemical communications (Cambridge, England), (42), 4404-6. https://doi.org/10.1039/b610051a
Wilson, Andrew J, et al. "Amplification of chirality in benzene tricarboxamide helical supramolecular polymers." Chemical communications (Cambridge, England) vol. ,42 (2006): 4404-6. doi: https://doi.org/10.1039/b610051a
Wilson AJ, van Gestel J, Sijbesma RP, Meijer EW. Amplification of chirality in benzene tricarboxamide helical supramolecular polymers. Chem Commun (Camb). 2006 Nov 13;(42):4404-6. doi: 10.1039/b610051a. Epub 2006 Sep 13. PMID: 17057858.
Copy Download .nbib Format: NLM
Impact of steric interactions on the helical transition in assemblies of discotic molecules.

Langmuir : the ACS journal of surfaces and colloids

van Gestel J, van der Schoot P.
PMID: 16378458
Langmuir. 2006 Jan 03;22(1):446-52. doi: 10.1021/la0521903.

We investigate theoretically the effect of excluded-volume interactions on the helical configurational transition of supramolecular assemblies in solutions of chiral disklike molecules. To this end, we set up a second-virial theory within the context of the helical self-assembly of...

Cite
van Gestel J, van der Schoot P. Impact of steric interactions on the helical transition in assemblies of discotic molecules. Langmuir. 2006;22(1):446-52doi: 10.1021/la0521903.
van Gestel, J., & van der Schoot, P. (2006). Impact of steric interactions on the helical transition in assemblies of discotic molecules. Langmuir : the ACS journal of surfaces and colloids, 22(1), 446-52. https://doi.org/10.1021/la0521903
van Gestel, Jeroen, and van der Schoot, Paul. "Impact of steric interactions on the helical transition in assemblies of discotic molecules." Langmuir : the ACS journal of surfaces and colloids vol. 22,1 (2006): 446-52. doi: https://doi.org/10.1021/la0521903
van Gestel J, van der Schoot P. Impact of steric interactions on the helical transition in assemblies of discotic molecules. Langmuir. 2006 Jan 03;22(1):446-52. doi: 10.1021/la0521903. PMID: 16378458.
Copy Download .nbib Format: NLM
Financial time series prediction using least squares support vector machines within the evidence framework.

IEEE transactions on neural networks

Van Gestel T, Suykens JK, Baestaens DE, Lambrechts A, Lanckriet G, Vandaele B, De Moor B, Vandewalle J.
PMID: 18249915
IEEE Trans Neural Netw. 2001;12(4):809-21. doi: 10.1109/72.935093.

The Bayesian evidence framework is applied in this paper to least squares support vector machine (LS-SVM) regression in order to infer nonlinear models for predicting a financial time series and the related volatility. On the first level of inference,...

Cite
Van Gestel T, Suykens JK, Baestaens DE, et al. Financial time series prediction using least squares support vector machines within the evidence framework. IEEE Trans Neural Netw. 2001;12(4):809-21doi: 10.1109/72.935093.
Van Gestel, T., Suykens, J. K., Baestaens, D. E., Lambrechts, A., Lanckriet, G., Vandaele, B., De Moor, B., & Vandewalle, J. (2001). Financial time series prediction using least squares support vector machines within the evidence framework. IEEE transactions on neural networks, 12(4), 809-21. https://doi.org/10.1109/72.935093
Van Gestel, T, et al. "Financial time series prediction using least squares support vector machines within the evidence framework." IEEE transactions on neural networks vol. 12,4 (2001): 809-21. doi: https://doi.org/10.1109/72.935093
Van Gestel T, Suykens JK, Baestaens DE, Lambrechts A, Lanckriet G, Vandaele B, De Moor B, Vandewalle J. Financial time series prediction using least squares support vector machines within the evidence framework. IEEE Trans Neural Netw. 2001;12(4):809-21. doi: 10.1109/72.935093. PMID: 18249915.
Copy Download .nbib Format: NLM
Incorporation of the biomarker concept in ecotoxicology calls for a redefinition of terms.

Ecotoxicology (London, England)

Van Gestel CA, Van Brummelen TC.
PMID: 24193812
Ecotoxicology. 1996 Aug;5(4):217-25. doi: 10.1007/BF00118992.

: Biomarkers have received a lot of attention but the biomarker concept has not yet been defined properly. As a consequence, various interpretations of the term 'biomarker' exist, some of which overlap with well-established ecotoxicological concepts. To allow incorporation...

Cite
Van Gestel CA, Van Brummelen TC. Incorporation of the biomarker concept in ecotoxicology calls for a redefinition of terms. Ecotoxicology. 1996;5(4):217-25doi: 10.1007/BF00118992.
Van Gestel, C. A., & Van Brummelen, T. C. (1996). Incorporation of the biomarker concept in ecotoxicology calls for a redefinition of terms. Ecotoxicology (London, England), 5(4), 217-25. https://doi.org/10.1007/BF00118992
Van Gestel, C A, and Van Brummelen, T C. "Incorporation of the biomarker concept in ecotoxicology calls for a redefinition of terms." Ecotoxicology (London, England) vol. 5,4 (1996): 217-25. doi: https://doi.org/10.1007/BF00118992
Van Gestel CA, Van Brummelen TC. Incorporation of the biomarker concept in ecotoxicology calls for a redefinition of terms. Ecotoxicology. 1996 Aug;5(4):217-25. doi: 10.1007/BF00118992. PMID: 24193812.
Copy Download .nbib Format: NLM
Measurement of the Neutron Lifetime by Counting Trapped Protons.

Journal of research of the National Institute of Standards and Technology

Wietfeldt FE, Dewey MS, Gilliam DM, Nico JS, Fei X, Snow WM, Greene GL, Pauwels J, Eykens R, Lamberty A, Van Gestel J.
PMID: 27308145
J Res Natl Inst Stand Technol. 2005 Aug 01;110(4):327-31. doi: 10.6028/jres.110.048. Print 2005.

We measured the neutron decay lifetime by counting in-beam neutron decay recoil protons trapped in a quasi-Penning trap. The absolute neutron beam fluence was measured by capture in a thin (6)LiF foil detector with known efficiency. The combination of...

Cite
Wietfeldt FE, Dewey MS, Gilliam DM, et al. Measurement of the Neutron Lifetime by Counting Trapped Protons. J Res Natl Inst Stand Technol. 2005;110(4):327-31doi: 10.6028/jres.110.048.
Wietfeldt, F. E., Dewey, M. S., Gilliam, D. M., Nico, J. S., Fei, X., Snow, W. M., Greene, G. L., Pauwels, J., Eykens, R., Lamberty, A., & Van Gestel, J. (2005). Measurement of the Neutron Lifetime by Counting Trapped Protons. Journal of research of the National Institute of Standards and Technology, 110(4), 327-31. https://doi.org/10.6028/jres.110.048
Wietfeldt, F E, et al. "Measurement of the Neutron Lifetime by Counting Trapped Protons." Journal of research of the National Institute of Standards and Technology vol. 110,4 (2005): 327-31. doi: https://doi.org/10.6028/jres.110.048
Wietfeldt FE, Dewey MS, Gilliam DM, Nico JS, Fei X, Snow WM, Greene GL, Pauwels J, Eykens R, Lamberty A, Van Gestel J. Measurement of the Neutron Lifetime by Counting Trapped Protons. J Res Natl Inst Stand Technol. 2005 Aug 01;110(4):327-31. doi: 10.6028/jres.110.048. Print 2005. PMID: 27308145; PMCID: PMC4852842.
Copy Download .nbib Format: NLM
Oligometastatic Disease Detection with .

Cancers

Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P.
PMID: 34638466
Cancers (Basel). 2021 Oct 04;13(19). doi: 10.3390/cancers13194982.

Metastasis-directed therapy (MDT) in oligometastatic prostate cancer has the potential of delaying the start of androgen deprivation therapy (ADT) and disease progression. We aimed to analyze the efficacy of PSMA-PET/CT in detecting oligometastatic disease (OMD), to look for predictive...

Cite
Artigas C, Diamand R, Shagera QA, et al. Oligometastatic Disease Detection with . Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13194982.
Artigas, C., Diamand, R., Shagera, Q. A., Plouznikoff, N., Fokoue, F., Otte, F. X., Gil, T., Peltier, A., Van Gestel, D., & Flamen, P. (2021). Oligometastatic Disease Detection with . Cancers, 13(19), . https://doi.org/10.3390/cancers13194982
Artigas, Carlos, et al. "Oligometastatic Disease Detection with ." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13194982
Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P. Oligometastatic Disease Detection with . Cancers (Basel). 2021 Oct 04;13(19). doi: 10.3390/cancers13194982. PMID: 34638466; PMCID: PMC8508549.
Copy Download .nbib Format: NLM
Aging-related modifications to G protein-coupled receptor signaling diversity.

Pharmacology & therapeutics

van Gastel J, Leysen H, Boddaert J, Vangenechten L, Luttrell LM, Martin B, Maudsley S.
PMID: 33316288
Pharmacol Ther. 2021 Jul;223:107793. doi: 10.1016/j.pharmthera.2020.107793. Epub 2020 Dec 13.

Aging is a highly complex molecular process, affecting nearly all tissue systems in humans and is the highest risk factor in developing neurodegenerative disorders such as Alzheimer's and Parkinson's disease, cardiovascular disease and Type 2 diabetes mellitus. The intense...

Cite
van Gastel J, Leysen H, Boddaert J, et al. Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacol Ther. 2020;223:107793doi: 10.1016/j.pharmthera.2020.107793.
van Gastel, J., Leysen, H., Boddaert, J., Vangenechten, L., Luttrell, L. M., Martin, B., & Maudsley, S. (2021). Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacology & therapeutics, 223107793. https://doi.org/10.1016/j.pharmthera.2020.107793
van Gastel, Jaana, et al. "Aging-related modifications to G protein-coupled receptor signaling diversity." Pharmacology & therapeutics vol. 223 (2021): 107793. doi: https://doi.org/10.1016/j.pharmthera.2020.107793
van Gastel J, Leysen H, Boddaert J, Vangenechten L, Luttrell LM, Martin B, Maudsley S. Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacol Ther. 2021 Jul;223:107793. doi: 10.1016/j.pharmthera.2020.107793. Epub 2020 Dec 13. PMID: 33316288.
Copy Download .nbib Format: NLM
Who accepts nudges? nudge acceptability from a self-regulation perspective.

PloS one

van Gestel LC, Adriaanse MA, de Ridder DTD.
PMID: 34860843
PLoS One. 2021 Dec 03;16(12):e0260531. doi: 10.1371/journal.pone.0260531. eCollection 2021.

BACKGROUND: Public acceptability of nudging is receiving increasingly more attention, but studies remain limited to evaluations of aspects of the nudge itself or (inferred intentions) of the nudger. Yet, it is important to investigate which individuals are likely to...

Cite
van Gestel LC, Adriaanse MA, de Ridder DTD. Who accepts nudges? nudge acceptability from a self-regulation perspective. PLoS One. 2021;16(12):e0260531doi: 10.1371/journal.pone.0260531.
van Gestel, L. C., Adriaanse, M. A., & de Ridder, D. T. D. (2021). Who accepts nudges? nudge acceptability from a self-regulation perspective. PloS one, 16(12), e0260531. https://doi.org/10.1371/journal.pone.0260531
van Gestel, Laurens C, et al. "Who accepts nudges? nudge acceptability from a self-regulation perspective." PloS one vol. 16,12 (2021): e0260531. doi: https://doi.org/10.1371/journal.pone.0260531
van Gestel LC, Adriaanse MA, de Ridder DTD. Who accepts nudges? nudge acceptability from a self-regulation perspective. PLoS One. 2021 Dec 03;16(12):e0260531. doi: 10.1371/journal.pone.0260531. eCollection 2021. PMID: 34860843; PMCID: PMC8641879.
Copy Download .nbib Format: NLM
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research.

Frontiers in oncology

Cogels MM, Rouas R, Ghanem GE, Martinive P, Awada A, Van Gestel D, Krayem M.
PMID: 34869042
Front Oncol. 2021 Nov 18;11:784947. doi: 10.3389/fonc.2021.784947. eCollection 2021.

Immunotherapy with checkpoint inhibitors opened new horizons in cancer treatment. Clinical trials for novel immunotherapies or unexplored combination regimens either need years of development or are simply impossible to perform like is the case in cancer patients with limited...

Cite
Cogels MM, Rouas R, Ghanem GE, et al. Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. Front Oncol. 2021;11:784947doi: 10.3389/fonc.2021.784947.
Cogels, M. M., Rouas, R., Ghanem, G. E., Martinive, P., Awada, A., Van Gestel, D., & Krayem, M. (2021). Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. Frontiers in oncology, 11784947. https://doi.org/10.3389/fonc.2021.784947
Cogels, Morgane M, et al. "Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research." Frontiers in oncology vol. 11 (2021): 784947. doi: https://doi.org/10.3389/fonc.2021.784947
Cogels MM, Rouas R, Ghanem GE, Martinive P, Awada A, Van Gestel D, Krayem M. Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. Front Oncol. 2021 Nov 18;11:784947. doi: 10.3389/fonc.2021.784947. eCollection 2021. PMID: 34869042; PMCID: PMC8636317.
Copy Download .nbib Format: NLM
Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab.

Journal of the European Academy of Dermatology and Venereology : JEADV

Orte Cano C, Van Meerhaeghe T, Tannous J, Lienard D, Van Gestel D, Cuylits N, Luce S, Carlot S, Le Moine A, Aspeslagh S, Del Marmol V.
PMID: 34855244
J Eur Acad Dermatol Venereol. 2022 Jan;36:53-58. doi: 10.1111/jdv.17658.

It is well known that organ transplant recipients are prone to develop non-melanoma skin cancers, particularly cutaneous squamous cell carcinoma (cSCC). This is explained by the long-term use of immunosuppressants and thus the decrease of the immunosurveillance that protects...

Cite
Orte Cano C, Van Meerhaeghe T, Tannous J, et al. Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab. J Eur Acad Dermatol Venereol. 2022;36:53-58doi: 10.1111/jdv.17658.
Orte Cano, C., Van Meerhaeghe, T., Tannous, J., Lienard, D., Van Gestel, D., Cuylits, N., Luce, S., Carlot, S., Le Moine, A., Aspeslagh, S., & Del Marmol, V. (2022). Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab. Journal of the European Academy of Dermatology and Venereology : JEADV, 3653-58. https://doi.org/10.1111/jdv.17658
Orte Cano, C, et al. "Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab." Journal of the European Academy of Dermatology and Venereology : JEADV vol. 36 (2022): 53-58. doi: https://doi.org/10.1111/jdv.17658
Orte Cano C, Van Meerhaeghe T, Tannous J, Lienard D, Van Gestel D, Cuylits N, Luce S, Carlot S, Le Moine A, Aspeslagh S, Del Marmol V. Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab. J Eur Acad Dermatol Venereol. 2022 Jan;36:53-58. doi: 10.1111/jdv.17658. PMID: 34855244.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 78 entries